Levocetirizine has a longer duration of action on improving total nasal symptoms score than fexofenadine after single administration
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Aims: To compare the onset and duration of action of the new antihistamine levocetirizine with that of the second‐generation antihistamine fexofenadine using the Vienna Challenge Chamber (VCC). The latter is an environment where subjects can be exposed to specific aeroallergens in controlled and reproducible conditions allowing for precise comparisons of anti‐allergic drugs. Methods: Ninety‐four subjects received a single dose of levocetirizine 5 mg, fexofenadine 120 mg or placebo in a random order using a three‐way cross‐over design. On day 1, subjects were exposed to grass pollens (1500 grains/m 3) in the VCC over a period of 4 h. Treatment was given 2 h after the start of challenge. On day 2, 22 h after drug intake, subjects were again exposed to pollens for 6 h. Specified symptoms were assessed by the subjects every 15 min using 5‐point scales. The main efficacy parameter was the change from baseline in the Major Symptom Complex Score (MSCS = sum of rhinorrhea, sneezing, itchy nose and eyes). Results: Baseline characteristics, including symptoms scores, were similar in the three study groups. During the first 2 h after drug intake both antihistamines achieved clinically relevant and significant (P < 0.001) improvements in symptom scores. Twenty‐two to 24 h after drug intake, mean (SEM) MSCS reductions were: 1.9 (0.3) after placebo (baseline of 9.7), 3.8 (0.3) after fexofenadine (baseline of 9.9), and 5.1 (0.3) after levocetirizine (baseline of 9.8). Levocetirizine was significantly (P < 0.001) more effective than fexofenadine with a score difference of 1.3 (95% CI 0.7, 1.9). This was maintained until the end of the study (up to 28 h). Conclusions: A rapid onset of action in alleviating seasonal allergic rhinitis (SAR) symptoms of subjects exposed to grass pollens in the VCC was observed after levocetirizine and fexofenadine. Levocetirizine was more effective than fexofenadine at and later than 22 h after drug intake, an indication of the longer‐duration of action of levocetirizine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stuck, B. A., Czajkowski, J., Hagner, A.-E., Klimek, L., Verse, T., Hörmann, K., & Maurer, J. T. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.12.589 · Cited by 181
First do no harm: Managing antihistamine impairment in patients with allergic rhinitis
Casale, T. B., Blaiss, M. S., Gelfand, E., Gilmore, T., Harvey, P. D., Hindmarch, I., Simons, F. E. R., Spangler, D. L., Szefler, S. J., Terndrup, T. E., et al. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.1550 · Cited by 139
Day, J. H., Briscoe, M. P., Rafeiro, E., & Ratz, J. D. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2004.0117.x · Cited by 87
Cited by
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
Wise, S. K., Lin, S. Y., Toskala, E., Orlandi, R. R., Akdis, C. A., Alt, J. A., Azar, A., Baroody, F. M., Bachert, C., Canonica, G. W., et al. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22073 · Cited by 557
International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Wise, S. K., Damask, C., Roland, L. T., Ebert, C., Levy, J. M., Lin, S., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23090 · Cited by 507
Zieglmayer, P., Zieglmayer, R., Bareille, P., Rousell, V., Salmon, E., & Horak, F. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802155792 · Cited by 35
Self-citationPollen starch granules in bronchial inflammation
Badorrek, P., Dick, M., Emmert, L., Schaumann, F., Koch, W., Hecker, H., Murdoch, R., Hohlfeld, J. M., & Krug, N. (2012) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2012.06.019 · Cited by 17
Metadata
- Authors
- Horak, F., Zieglmayer, P. U., Zieglmayer, R., Kavina, A., & Lemell, P.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2005-05-06
- Volume
- 60
- Issue
- 1
- Pages
- 24-31
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W2055269921
- Cited by
- 52
- References
- 3
- FWCI
- 3.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Levocetirizine has a longer duration of action on improving total nasal symptoms score than fexofenadine after single administration. https://app.cochat.ai/papers/10.1111/j.1365-2125.2005.02377.x
- The paper
- Horak, F., Zieglmayer, P. U., Zieglmayer, R., Kavina, A., & Lemell, P. (2005). Levocetirizine has a longer duration of action on improving total nasal symptoms score than fexofenadine after single administration. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.2005.02377.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.